About JHL Biotech
JHL Biotech is a Healthcare company based in Hsinchu (Taiwan) founded in 2012. Contract manufacturing solutions for biologics are provided to Asian companies. JHL Biotech has raised $186.6 million across 5 funding rounds from investors including Kleiner Perkins, Fubon Financial Holdings and Uni-President. JHL Biotech offers products and services including 10X Productive Book, Zen Boss, and Motivational Workshops. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Mammalian Cell Line.
Company details
JHL Biotech provides contract manufacturing solutions to companies developing and commercialising affordable biologic medicines in Asia. The company offers cell line cloning, process development, and manufacturing capabilities and services to emerging and established biopharmaceutical companies. Its services include antibody cloning, monoclonal antibody manufacturability and protein engineering, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, analytical assays, clinical manufacturing, and commercial manufacturing based on mammalian cell lines. The company has strategic development and manufacturing alliances with Selexis, Sanofi, and Aslan Pharmaceuticals, and BeiGene.
- Headquarters Hsinchu, Taiwan
- SectorsHealthcare
- Website jhlbiotech.com
- Social LinkedIn YouTube
- Total Equity Funding$186.6M (USD)
in 5 rounds
- InvestorsKleiner Perkins
& 10 more
Products & Services of JHL Biotech
JHL Biotech offers a comprehensive portfolio of products and services, including 10X Productive Book, Zen Boss, and Motivational Workshops.
Guide to achieving hyper productivity and efficient task management.
Resource for building effective teams and successful leadership practices.
Sessions on productivity and purpose for professional development.
Apps and channels of JHL Biotech
its YouTube channel AseemPuri has 193 subscribers and 30 videos.
Videos from JHL Biotech
The most watched videos on JHL Biotech's YouTube channel, AseemPuri (193 subscribers). Click a video to play it here.
More on AseemPuri.
Funding Insights of JHL Biotech
JHL Biotech has successfully raised a total of $186.6M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $186.6M
- Total Rounds 5
- First Round $35M
(Jun 2014)
- Investors Count 11
All 5 funding rounds of JHL Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2018 | Series D | – | – | ||
| May 2018 | $106M | Series D | – | – | |
| Dec 2016 | $81.44M | Post-IPO | – | – | |
| May 2015 | $45.6M | Series C | – | – | |
| Jun 2014 | $35M | Series B | – | – |
11 investors in total: 11 institutional.
Investors in JHL Biotech
JHL Biotech has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Kleiner Perkins, Fubon Financial Holdings and Uni-President.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| mcmchina.com | ||||
BioVenture is focused on early and growth-stage healthcare investments. | 2013 | bioventure.com.cn | Suzhou, China | |
Life and property insurance services are provided via internet-first platforms. | 2001 | fubon.com | Taipei, Taiwan | |
Sector-agnostic investments are made in early-stage Asia Pacific startups. | 1959 | cdibcapitalgroup.com | Taipei, Taiwan | |
Stage agnostic VC firm investing majorly in North America | biomarkcapital.com | San Francisco, United States | ||
| hotung.com.tw | ||||
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
Pharmaceutical and nutraceutical products are developed across seven therapeutic areas. | 1973 | sanofi.com | Paris, France | |
Dairy products, beverages, snacks, and instant noodles are produced. | 1967 | uni-president.com | Tainan, Taiwan | |
Commercial bank | 2002 | taishinholdings.com.tw | Taipei, Taiwan |
Investor details for JHL Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of JHL Biotech
3 dated milestones of JHL Biotech across 6 years, from founding to its latest funding, stage changes and deals.
- Founded JHL Biotech is founded.
- Funding First funding round of $35.0M.
- Funding Latest funding round, Series D,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jhl Biotech
Complete news archive for JHL Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JHL Biotech
JHL Biotech was founded in 2012 and raised its 1st funding round 2 years after it was founded.
JHL Biotech is headquartered in Hsinchu, Taiwan.
JHL Biotech is a funded company, having raised a total of $186.6M across 5 funding rounds to date. The company's 1st funding round was a Series B of $35M, raised on Jun 2014.
JHL Biotech provides contract manufacturing solutions to companies developing and commercialising affordable biologic medicines in Asia. The company offers cell line cloning, process development, and manufacturing capabilities and services to emerging and established biopharmaceutical companies. Its services include antibody cloning, monoclonal antibody manufacturability and protein engineering, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, analytical assays, clinical manufacturing, and commercial manufacturing based on mammalian cell lines. The company has strategic development and manufacturing alliances with Selexis, Sanofi, and Aslan Pharmaceuticals, and BeiGene.
JHL Biotech offers 10X Productive Book, Zen Boss, and Motivational Workshops.
JHL Biotech has 11 investors. Key investors include Kleiner Perkins, Fubon Financial Holdings, Uni-President, Sanofi, and CDIB Capital Group.